Morton Collins, Director at INOVIO PHARMACEUTICALS, INC. (INO), bought 26,600 shares at $9.73 ($259K) on 2014-08-20, disclosed to the SEC on 2014-08-21.
Open-market purchase of $259k INO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.71 | 4,600 | $45K | 17.2% |
| 2 | $9.72 | 1,800 | $17K | 6.8% |
| 3 | $9.73 | 1,700 | $17K | 6.4% |
| 4 | $9.73 | 4,500 | $44K | 16.9% |
| 5 | $9.75 | 14,000 | $137K | 52.7% |
| Total | $9.74 avg | 26,600 |
| $259K |
| 100% |
| Filing → |
| INO | BUY | 2017-03-28 | $133K | — | Filing → |
| INO | BUY | 2016-06-29 | $183K | — | Filing → |
| KOPN | BUY | 2016-05-20 | $106K | — | Filing → |